Financials

MDxHealth operates on a calendar basis with its accounting year ending on December 31.

The company reports its consolidated financial statements under International Financial Reporting Standards (IFRS) and all amounts are in US Dollars. MDxHealth publishes a consolidated and audited Annual Report on an annual basis, a consolidated Interim Report for its June 30 half-year financial figures, and business/financial updates at the end of Q1 and Q3. Furthermore, for the Annual General Shareholders’ Meeting, the company also publishes the non-consolidated Belgian-GAAP financial statements of the parent company. Prior to October 5, 2010, MDxHealth operated under the name OncoMethylome Sciences.

 

2019 Reporting Calendar

  • January 14: Business update and preliminary FY2018 results
  • February 28: Publication of FY2018 results
  • April 24: Publication of first interim trading update
  • May 29: AGSM
  • August 29: Publication of HY2019 results
  • November 11: Publication of second interim trading update

 

3-year Snapshot  
Condensed Consolidated Statement of Comprehensive Income
In '000 of USD 2018 2017 2016
Revenues 28,397 40,508 29,970
Gross Profit 16,745 30,305 19,867
Research and Development Expenses (4,280) (3,505) (1,977)
Selling, General and Adminisitrative Expenses (44,798) (39,142) (30,953)
Other Operating (Income)/Expenses 235 68 217
Other Profit/(Loss)(Ebit) (32,098) (12,274) (12,846)
Financial Income 21 10 36
Financial Expenses (414) (137) (477)
Income Taxes 41 113   113
Net Profit/(Loss (32,450) (12,288) (13,147)
       
Consolidated Statement of Financial Position
In '000 of USD      
Assets 2018 2017 2016
Total Non-Current Assets 17,613 19,205 16,233
Total Current Assets 47,863 39,316 51,488
Of Which Cash and Cash Equivalents 26,203 16,827 30,871
Total Assets 65,476 58,521 67,721
       
Liabilities and Shareholders’ Equity      
Total Equity 52,117 43,546 52,741
Non-Current Liabilities 1,882 1,860 2,387
Current Liabilities 11,477 13,115 12,593
       
Consolidated Cash Flow Statement      
In '000 of USD 2018 2017 2016
Operating Cash Flow (28,409) (10,489) (16,585)
Investing Cash Flow (1,726) (6,053) (5,316)
Financing Cash Flow 41,919 573 21,095
Net Change in Cash and Cash Equivalents 11,784 (15,969) (806)
Cash and Cash Equivalents at End of Period 26,203 16,827 30,871

Financial Reports

2019

2018

2017

  • Auditors Opinion: english français
  • Board Report on 2017 Financial Statements "after correction to take into account a clerical drafting error": english français
  • 2017 Consolidated figures: english
  • 2017 Interim report: english français
  • 2017 Annual Report "after correction to take into account a clerical drafting error": english français
  • Full year 2017 Non Consolidated Statutory Account: français

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

  • Full year 2006 Registration Document (Annual Report): english français
  • 2006 Full Year Results: english français
  • 2006 Full Year Results Financial Report: english
  • Statutory Statements with Reports of Board and Auditor: english
  • 2006 Half year Report (June 30 figures): français